Abstract
guidelines. Informed consent was obtained from all participants. The protocol was approved by the Western Institutional Review Board and the Ethical Review Committee for Research in Human Subjects of the Ministry of Public Health. Of 565 women in Group A: 28 (5.0%) had no visible squamocolumnar junction (SCJ); 464 (82.1%) were VIA negative; 54 (9.6%) were VIA positive; 1 (0.2%) had suspect cancer; and 18 (3.2%) were classified as other. A total of 526 women received ECC and/or biopsy, of whom 2 had cervical intraepithelial neoplasia (CIN) grade 2/3. Of 3562 women in Group B: 147 (4.1%) had no visible SCJ; 3275 (91.9%) had negative VIA results; 133 (3.7%) were VIA positive; 0 had suspect cancer; and 7 (0.1%) were classified as other. There were 287 women who received colposcopy at the district hospital; of these 287 women, 133 (46.3%) were VIA positive, 147 (51.2%) had no visible SCJ, and 2 (0.7%) were unknown. Five women subsequently underwent hysterectomy, and 3 of 277 women who received ECC and/or biopsy had CIN 2/3. The VIA positivity rate on follow-up testing for both previously VIA negative and positive cohorts was exceedingly low (3.7% and 9.6%, respectively). Based on these results, rescreening with VIA at longer intervals may be warranted in low-resource settings.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Gynecology and Obstetrics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
